Related Experiment Videos
Innate (over)immunity and adaptive autoimmune disease.
1University Hospital Bruderholz, Institute of Internal Medicine, Switzerland. mike.recher@ksbh.ch
Current Topics in Microbiology and Immunology
|May 27, 2006
Summary
Autoimmune diseases arise from adaptive immune responses but often begin with autoreactivity. Innate immune system activation and target organ inflammation critically influence the transition from autoreactivity to autoimmune disease.
Area of Science:
- Immunology
- Autoimmunity
- Innate and Adaptive Immunity
Background:
- Autoimmune diseases manifest clinically via adaptive immune responses (T and B cells) targeting self-antigens.
- Autoreactivity, the initial priming of self-reactive immune cells without tissue damage, often precedes overt autoimmune disease.
Purpose of the Study:
- To discuss the role of the innate immune system and local inflammation in the development of autoimmune diseases.
- To explore the transition from autoreactivity to clinical autoimmunity.
Main Methods:
- Review of recent experimental evidence on immune system regulation.
- Analysis of factors influencing autoimmune disease onset.
Main Results:
- Both autoreactivity induction and its progression to autoimmune disease are regulated by innate immune system activation.
- The inflammatory state of the target organ significantly impacts the manifestation of autoimmune disease.
Conclusions:
- The innate immune system plays a crucial role in controlling the development of autoimmune diseases.
- Local tissue inflammation is a key determinant in the onset of clinical autoimmune conditions.